drugset / Trial / NCT00598962
Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease
Phase 4
Completed
58 enrolled
The University of Texas Health Science Center at Tyler
Pfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
To determine the safety and efficacy of azithromycin, rifabutin and ethambutol given three times weekly in the treatment of lung infection with M. avium complex(MAC)
Timeline
- Start
- 1994-12
- Primary completion
- 2006-11
- Completion
- 2017-05-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | — | — |
| Subject | Rifabutin | Small molecule | — | — |
| Subject | Rifampin | Small molecule | — | — |